ERISA External Review & Mental Health Parity (MHPAEA) Appeals

The Power of the Mental Health Parity Act (MHPAEA)

Enacted in 2008 and strengthened by federal rules in 2024, the Mental Health Parity and Addiction Equity Act (MHPAEA) prohibits health plans from imposing greater restrictions on mental health or substance use disorder benefits than on medical or surgical benefits.

If an insurer requires weekly utilization review for a patient in residential addiction treatment, but does not require weekly concurrent review for a patient recovering in a skilled nursing facility, that represents a potential Non-Quantitative Treatment Limitation (NQTL) parity violation under federal law.

The 3 Levels of Insurance Appeal

Under the Employee Retirement Income Security Act (ERISA), participants in employer-sponsored health plans have federally protected appeal rights:

Level 1Within 180 Days of Denial

Internal Appeal to Payer

A formal written challenge submitted directly to the payer's appeals department. Must include the full clinical chart, ASAM documentation, treatment plan, and a rebuttal letter disproving the payer's specific denial rationale.

Level 2Within 60 Days of Level 1 Denial

Second Internal Grievance (Optional by Plan)

For plans with a two-level internal process. Evaluated by a clinical medical director who was not involved in the original denial or Level 1 review.

Level 3Within 4 Months of Final Internal Denial

Binding External Review (IRO)

An independent clinical panel assigned by the state insurance department or federal HHS/DOL. The IRO's determination is legally binding on the insurance company; if overturned, the payer must process and pay the claim.

What to Include in an Independent External Review Packet

To maximize your probability of an overturn at the IRO level, compile a comprehensive evidentiary packet including:

Authorized Representative Designation: Form signed by the patient authorizing your practice to appeal on their behalf.

Payer Denial Letters & CARC Explanations: Copies of all initial, Level 1, and Level 2 adverse determination notices.

Objective Clinical Timeline: Progress notes explicitly mapped to the 6 ASAM dimensions or DSM-5 functional criteria.

Treating Provider Letter of Medical Necessity: Signed letter from the clinical director or attending physician refuting the payer's specific denial rationale point-by-point.

Citation of Published Guidelines: Excerpts from ASAM, APA (American Psychiatric Association), or AACAP practice parameters supporting the level of care.

Prevention Beats Litigation

While ERISA external reviews are powerful tools for recovering $10,000+ in denied claims, preventing front-end rejections via automated eligibility verification and pre-service prior authorization checks remains the most cost-effective practice strategy.

Frequently Asked Questions on ERISA & Parity Appeals

Frequently asked questions

What is an Independent Review Organization (IRO)?

An Independent Review Organization (IRO) is an accredited third-party entity completely independent of both the healthcare provider and the insurance company. Under the federal Affordable Care Act and ERISA regulations, patients and authorized providers have the legal right to submit adverse insurance determinations to an IRO for a binding clinical review.

What is a Non-Quantitative Treatment Limitation (NQTL) under MHPAEA?

An NQTL is any limitation on the scope or duration of treatment that is not expressed numerically (unlike copays or visit caps). Examples include prior authorization requirements, medical necessity criteria, step-therapy fail-first protocols, and network admission standards. Under the Mental Health Parity and Addiction Equity Act (MHPAEA), an insurer cannot apply NQTLs to mental health or substance use disorder benefits more stringently than to medical/surgical benefits.

What is the overturn rate for behavioral health external reviews?

Published state insurance commissioner data and federal audits demonstrate that independent medical reviewers overturn insurer denials in 45% to 65% of behavioral health and addiction treatment external reviews—particularly when clinical documentation strictly follows ASAM criteria.

Who can file an ERISA external review?

The patient, their legal guardian, or an authorized representative (such as the treating clinical facility or billing advocate holding a valid, signed Appointment of Designated Representative form) can file an external review.

A verification reflects what the payer had on file at the time of the check. It is not a guarantee of payment. Coverage can change mid-year, and retroactive terminations happen. Keep your reference number.